Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Autor: VELLA, Marco, Alonge, V.

VENGONO AFFRONTATI GLI ASPETTI EPIDEMIOLOGICI E LA FISIOPATOLOGIA CHE SOTTENDE LA CALCOLOSI URINARIA. LA CLINICA DELLA LITIASI URINARIA, LE SUE COMPLICANZE E LE DIVERSE STRATEGIE TERAPEUTICHE RICCA L''ICONOGRAFIA E LA PRESENZA DI TABELLE RIASSUNTIVE.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ed2db82fda1bac83cd0a6615313449da
http://hdl.handle.net/10447/58531

Zobrazit plný text záznamu

FIBRONECTIN (FN) AND UROTHELIAL DAMAGE SECONDARY TO ADJUVANT INTRAVESICAL THERAPY

Autor: Carità, G, Alonge, V, Scurria, S, Gattuso, S, Caruso, S, RUSSO, Antonio, D'ARIENZO, Michele, SERRETTA, Vincenzo

Introduction and Objectives: Intravesical chemotherapy has been proven effective in preventing recurrence of low-risk non-muscle invasive bladder cancer (NMIBC). BCG is recognised as the best conservative treatment for intermediate and high risk NMIB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::87097e1f9bf25d65bbe7180bc4abc26f
http://hdl.handle.net/10447/99975

Zobrazit plný text záznamu

PATIENT’S COMPLIANCE TO BCG. DO WE ADEQUATELY CONSIDER IT?

Autor: Scalici, CG, Alonge, V, Gattuso, S, Carità,G, Rocchini, L, Moschini, M, Colombo, R., SERRETTA, Vincenzo

Introduction: Several studies and meta-analysis demonstrated that BCG is the best treatment for conservative management of high-risk NMI-BC with a net benefit in terms of both recurrence-free and progression-free survival (1, 2). Maintenance lasting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::7f217e927615d1c0ebaa3a0509ad8f89
http://hdl.handle.net/10447/99973

Zobrazit plný text záznamu

PATIENT’S COMPLIANCE TO INTRAVESCICAL BCG IN ROUTINE CLINICAL PRACTICE, RETROSPECTIVE ANALYSIS OF 411 CONSECUTIVE PATIENTS

Autor: SERRETTA, Vincenzo, Alonge, V, Scalici Gesolfo, C, D’Amato, F, Solazzo, A, Rocchini, L, Moschini, M, Colombo, R.

Aim of the study BCG maintenance for at least one year is advocated by urological guidelines as the best intravesical regimen in high-risk non muscle invasive bladder cancer (NMIBC), conservatively treated. Noteworthy, a relevant percentage of patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::9087d660742ee6cde2e2c896aa85f346
http://hdl.handle.net/10447/99997

Zobrazit plný text záznamu

BIOMARKERS OF UROTHELIAL DAMAGE IN PATIENTS TREATED BY ADJUVANT INTRAVESICAL THERAPY

Autor: Chiapparrone,G, Alonge,V, Caruso,S, Fanale,D, RUSSO, Antonio, Giaimo,RM, Sommatino,F, SERRETTA, Vincenzo

Introduction/Aim: Chemotherapy or BCG given intravesically to prevent recurrence after transurethral resection (TUR) of non-muscle invasive bladder cancer (NMI-BC) cause frequent, sometime severe, local toxicity. As a consequence, many patients do no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::4e12629f7f0b27411e828cdc34f22019
http://hdl.handle.net/10447/73087

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání